German firm Carl Zeiss sees growing demand for eye care tech in India
The Hindu
German tech firm Carl Zeiss boosts AI-driven medical device market in India with rising DR cases & increasing diabetic population.
Carl Zeiss, a German technology firm that manufactures optical systems and optoelectronics, said India has been a booming market for its artificial intelligence (AI) driven medical devices as the country witnessed a spike in diabetic retinopathy (DR) cases in recent years.
AI in medicine was a boon in the management of diseases like DR as the technology assists in screening patients and enables early detection of symptoms, enabling timely treatment, said Dipu Bose, Head, Carl Zeiss Meditec, India & Neighbouring Markets.
Latest data from the Indian Council of Medical Research published in 2023, shows the prevalence of diabetes in India reached an alarming 10.1 crore. According to the International Diabetes Federation (IDF), in 2021, there were an estimated 77 million adults living with diabetes in the country, accounting for 1 in 7 adults worldwide who are living with diabetes. Also, DR contributed significantly to cases of blindness in the country, reported the National Programme for Control of Blindness and Visual Impairment.
“The integration of AI and diagnostic imaging promises effective management of DR,’‘ Mr. Bose said. He also claimed that “demand for Zeiss products in India has been steadily rising. As the country’s healthcare landscape modernises, innovative imaging equipment is gaining importance and our offerings including ophthalmic diagnostic tools are finding fast acceptance among leading eye-care providers in the country.”
Zeiss’ medical devices are also used for rear of an eye photography, helps in diagnosing conditions like cataracts, age-related macular degeneration, and other eye diseases.
“Our R&D centres in India employ 500 engineers and technicians. They actively contribute to the design and development of products and tools for the local and global markets,’‘ Mr. Bose added.
The ZEISS Group generated an annual revenue of more than 10 billion euros in the October-September fiscal last year with India contributing ₹1800 crore to it.
Rupee strengthens against US dollar on weaker greenback and lower crude oil prices, despite foreign fund outflows.
Meta has hired Apple AI researchers Mark Lee and Tom Gunter for its Superintelligence Labs team, Bloomberg News reported.
OpenAI has said it will turn its for-profit company into a public benefit corporation.
China leads global green energy race with strategic planning, massive investments, and control over supply chain and technology.
Kenvue launches Cough Clinics with API to train doctors for effective cough diagnosis and treatment in India.
A list put out by LinkedIn highlights tier-2 and tier-3 growth pockets for professionals looking to relocate, tap into new industries or grow their careers locally
DLF Ltd. enters Mumbai with premium residential project The Westpark in Andheri West, targeting businessmen, professionals, and film industry.
Zoho unveils AI platforms including Zia LLM, Zia Agent Studio, and MCP server, emphasizing privacy and efficiency.
Axis Bank's Q1 FY26 financial report shows a 4% decline in net profit, growth in NII, and impact on asset quality.
PNGRB directs CGD entities to supply piped natural gas uniformly to domestic consumers, addressing pricing discrepancies and misuse concerns.
Wipro's Q1 results show growth in net profit, revenue, and large deal bookings despite challenges in the IT services market.
Adani Group sells 20% stake in AWL Agri Business to Wilmar International for ₹7,150 crore.
Sensex and Nifty drop as IT shares sell off, investors cautious ahead of U.S.-India trade talks outcome.